|
|
|
|
REDUCED INCIDENCE OF HEPATOCELLULAR CARCINOMA IN HIV/HBV-COINFECTED PATIENTS RECEIVING TENOFOVIR
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
G. Wandeler, D. Kraus, M. Egger, E. Bernasconi, D. Braun, M. Battegay, A. Calmy, M. Cavassini, P. Schmid, H. Furrer, A. Rauch and the Swiss HIV Cohort Study
|
|
|
|
|
|
|